DarioHealth Forms $ 30M Strategic Agreement with Sanofi US


What You Should Know:

DarioHealth Corp.., a provider of global digital therapeutics (DTx), announced it has entered into a $ 30M multi-year, strategic agreement with Sanofi US, an innovative global healthcare company. The multi-year, $ 30 million-dollar agreement will help accelerate commercial adoption of Dario’s full suite of digital therapeutics and drive the expansion of digital health solutions on the Dario platform.

– As part of the strategic agreement, Dario and Sanofi will collaborate on promoting the Dario multi-condition digital therapeutics solution, significantly increasing Dario’s sales reach in the health plan market and selectively in the employer channel.

Commercial Growth for Dario and the Development of Digital Health Solutions on Dario’s Platform

Sanofi selected Dario to leverage its broad suite of digital therapeutics and its ability to engage patients for favorable clinical and financial outcomes, as the solution of choice for its US commercial clients. Dario’s single platform helps patients manage diabetes, hypertension, weight management, musculoskeletal and behavioral health, offering Sanofi managed care clients an attractive, easily scalable digital health solution that creates immediate access across a wide range of needs.

In addition, the agreement calls for Dario and Sanofi to develop new or enhanced solutions leveraging the Dario platform, and for the parties to generate robust evidence to support future commercialization in the health plan channel.

“We are thrilled to be chosen by Sanofi to expand into the digital health market. We believe that this is the first time that a large biopharmaceutical company and a digital health company are collaborating to commercialize digital health solutions in the US market. Dario’s proven digital therapeutic solutions and innovative technologies provide the perfect complement to Sanofi’s scientific expertise, market access and scale, creating a foundation for long-term success in support of Sanofi’s goal of expanding into digital health therapies for chronic conditions, ”said Erez Raphael, CEO, DarioHealth.

Source link